Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
eMedicine - Tetralogy of Fallot : Article by

Quick Find
Authors & Editors
Introduction
Clinical
Differentials
Workup
Treatment
Medication
Follow-up
Miscellaneous
Multimedia
References

Related Articles
Acute Respiratory Distress Syndrome

Anemia, Acute

Anemia, Sickle Cell

Aortic Stenosis

Asthma

Patent Ductus Arteriosus

Pediatrics, Apnea

Pediatrics, Bacteremia and Sepsis

Pediatrics, Bronchiolitis

Pediatrics, Crying Child

Pediatrics, Foreign Body Ingestion

Pediatrics, Pneumonia

Pediatrics, Reactive Airway Disease

Pediatrics, Respiratory Distress Syndrome

Pneumothorax, Iatrogenic, Spontaneous and Pneumomediastinum

Pulmonic Valvular Stenosis

Shock, Cardiogenic

Shock, Septic




Patient Education
Heart Center

Tetralogy of Fallot Overview

Tetralogy of Fallot Causes

Tetralogy of Fallot Symptoms

Tetralogy of Fallot Treatment




Author: Mark Spektor, DO, Medical Director, Department of Emergency Medicine, Maimonides Medical Center

Mark Spektor is a member of the following medical societies: American College of Emergency Physicians, American College of Physician Executives, and Society for Academic Emergency Medicine

Coauthor(s): Kurt Pflieger, MD, Active Staff, Department of Pediatrics, Lake Pointe Medical Center

Editors: Theodore J Gaeta, DO, MPH, FACEP, Clinical Associate Professor, Department of Emergency Medicine, Joan and Sanford Weill Medical College at Cornell University; Vice Chairman and Program Director of Emergency Medicine Residency Program, Department of Emergency Medicine, New York Methodist Hospital; Academic Chair, Adjunct Professor, Department of Emergency Medicine, St George's University School of Medicine; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Gary Setnik, MD, Chair, Department of Emergency Medicine, Mount Auburn Hospital; Assistant Professor, Division of Emergency Medicine, Harvard Medical School; John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center; Charles V Pollack, Jr, MD, MA, FACEP, Professor, Department of Emergency Medicine, University of Pennsylvania College of Medicine; Chairman, Department of Emergency Medicine, Pennsylvania Hospital

Author and Editor Disclosure

Synonyms and related keywords: TOF, Fallot tetrad, Fallot's tetrad, congenital heart disease, tetralogy of Fallot, maldevelopment of right ventricular infundibulum, subaortic ventricular septal defect, right ventricular infundibular stenosis, aortic valve positioned to override the right ventricle, right ventricular hypertrophy, right-to-left shunting, right ventricular outflowtractobstruction, cyanosis, hypertrophy of the infundibular septum, dyspnea, retarded growth, aortic ejection click, systolic thrill, systolic ejection murmur, clubbing, scoliosis, squatting position, retinal engorgement, hemoptysis, conotruncal abnormalities, DiGeorge syndrome, branchial arch abnormalities, fetal hydantoin syndrome, fetal carbamazepine syndrome, fetal alcohol syndrome, maternalphenylketonuria birth defects

Background

Tetralogy of Fallot (TOF) is a complex of anatomic abnormalities arising from the maldevelopment of the right ventricular infundibulum.

In 1888, Fallot described the anatomy as consisting of a subaortic ventricular septal defect (VSD), right ventricular infundibular stenosis, aortic valve positioned to override the right ventricle, and right ventricular hypertrophy (RVH). See Image 1 for a schematic illustration of these abnormalities.

Pathophysiology

Wide variation exists in the basic anatomic morphology, pathophysiology, clinical signs and symptoms, and surgical methods of therapy. Pathophysiology is dependent primarily upon severity of the right ventricular outflow tract (RVOT) obstruction. Right-to-left shunting is typical.

Frequency

United States

TOF represents approximately 10% of cases of congenital heart disease.

Mortality/Morbidity

Natural history is variable.

  • Natural history is determined mainly by the degree of RVOT obstruction.
  • Approximately 25% of untreated patients with TOF and RVOT obstruction die within the first year of life, 40% by 4 years, 70% by 10 years, and 95% by 40 years.

Sex

Incidence is slightly higher in males than females.

Age

Newborns



History

  • Cyanosis develops within the first few years of life.
  • First presentation may include poor feeding, fussiness, tachypnea, and agitation.
  • Symptoms generally progress secondary to hypertrophy of the infundibular septum.
  • Cyanosis occurs and demands surgical repair.
  • Dyspnea on exertion is common.
  • Squatting is uniquely characteristic of a right-to-left shunt that presents in the exercising child.
  • Hypoxic "tet" spells are potentially lethal, unpredictable episodes that occur even in noncyanotic patients with TOF. These spells can be aborted with relatively simple procedures.
  • The rare patient may remain marginally and imperceptibly cyanotic, or acyanotic and asymptomatic, into adult life.
  • Severe cyanosis may present at birth in a patient with TOF and associated pulmonary atresia.
  • Birth weight is low.
  • Growth is retarded.
  • Development and puberty may be delayed.

Physical

  • Right ventricular predominance on palpation
  • May have a bulging left hemithorax
  • Systolic thrill at the lower left sternal border
  • Aortic ejection click
  • Single S2 - Pulmonic valve closure not heard
  • Systolic ejection murmur - Varies in intensity inversely with the degree of RVOT obstruction
    • More cyanotic patients have greater obstruction and a softer murmur.
    • An acyanotic patient with TOF (pink tet) has a long, loud, systolic murmur with a thrill along the RVOT.
  • Cyanosis and clubbing - Variable
  • Squatting position
  • Scoliosis - Common
  • Retinal engorgement
  • Hemoptysis

Causes

  • As one of the conotruncal malformations, TOF can be associated with a spectrum of lesions known as CATCH 22 (cardiac defects, abnormal facies, thymic hypoplasia, cleft palate, hypocalcemia). Cytogenetic analysis may demonstrate deletions of a segment of chromosome band 22q11 (DiGeorge critical region).
  • Ablation of cells of the neural crest has been shown to reproduce conotruncal malformations.
  • These abnormalities are associated with the DiGeorge syndrome and branchial arch abnormalities.
  • TOF frequently is associated with the following:
    • Fetal hydantoin syndrome
    • Fetal carbamazepine syndrome
    • Fetal alcohol syndrome
    • Maternal phenylketonuria (PKU) birth defects



Acute Respiratory Distress Syndrome
Anemia, Acute
Anemia, Sickle Cell
Aortic Stenosis
Asthma
Patent Ductus Arteriosus
Pediatrics, Apnea
Pediatrics, Bacteremia and Sepsis
Pediatrics, Bronchiolitis
Pediatrics, Crying Child
Pediatrics, Foreign Body Ingestion
Pediatrics, Pneumonia
Pediatrics, Reactive Airway Disease
Pediatrics, Respiratory Distress Syndrome
Pneumothorax, Iatrogenic, Spontaneous and Pneumomediastinum
Pulmonic Valvular Stenosis
Shock, Cardiogenic
Shock, Septic

Other Problems to be Considered

Ebstein malformation of the tricuspid valve
Pulmonary atresia
Ventricular septal defect
Pseudotruncus arteriosus



Lab Studies

  • Oximetry and arterial blood gases
    • Oxygen saturation is variable, but pH and pCO2 are normal unless the patient is in extremis, such as during a tet spell.
    • Oximetry is particularly useful in the dark-skinned patient or the anemic patient whose level of cyanosis is not apparent.
    • Cyanosis is not evident until 3-5 g/dL of reduced hemoglobin is present.
    • A decrease in systemic vascular resistance (SVR) during exercise, bathing, or fever potentiates a right-to-left shunt and causes hypoxemia.
  • Hematology
    • Prolonged cyanosis causes reactive polycythemia that increases the oxygen-carrying capacity.
    • Hyperviscosity and coagulopathy often ensue and are particularly deleterious in patients with a right-to-left intracardiac shunt.
    • Stroke and brain abscess are natural corollaries.

Imaging Studies

  • Chest roentgenography
    • Coeur en sabot (boot-shaped heart) secondary to uplifting of the cardiac apex from RVH and the absence of a normal main pulmonary artery segment (see Image 2)
    • Normal heart size due to the lack of pulmonary blood flow and congestive heart failure
    • Decreased pulmonary vascularity
    • Right atrial enlargement
    • Right-sided aortic arch (20-25% of patients) with indentation of leftward-positioned tracheobronchial shadow
    • May be normal in acyanotic TOF or may resemble findings of small- to moderate-sized VSD with mild RVH, right atrial enlargement, and increased pulmonary vascular markings
  • Echocardiography reveals a large VSD with an overriding aorta and variable degrees of RVOT obstruction.

Other Tests

  • Electrocardiogram (see Image 3)
    • Right axis deviation (+120° to +150°)
    • Right or combined ventricular hypertrophy
    • Right atrial hypertrophy

Procedures

  • Cardiac catheterization
    • Assesses pulmonary annulus size and pulmonary arteries
    • Assesses the severity of RVOT obstruction
    • Locates the position and size of the VSD
    • Rules out possible coronary artery anomalies



Prehospital Care

  • Any infant with cyanosis and/or respiratory distress requires oxygen.
  • Blow-by O2 (BBO2) is the least objectionable. Use the open-end of a cannula or tube.
  • Permit the baby to remain with the mother or father.
  • Do not provoke the infant by attempting to start an intravenous (IV) line, especially if not skilled in pediatric IV starts.
  • An intraosseous insertion could be an immediate lifesaving tool.

Emergency Department Care

The ED physician should be able to recognize and treat a hypercyanotic episode as one of the very few pediatric cardiology emergencies that may present to the ED.

  • Hypoxic tet spell: Hypercyanotic episodes are characterized by paroxysms of hyperpnea, prolonged crying, intense cyanosis, and decreased intensity of the murmur of pulmonic stenosis.
    • Mechanism - Secondary to infundibular spasm and/or decreased SVR with increased right-to-left shunting at the VSD, resulting in diminished pulmonary blood flow
    • If left untreated, may result in syncope, seizure, stroke, or death
  • Treatment for the acute setting of hypercyanosis includes the following:
    • Knee-chest position: Place the baby on the mother's shoulder with the knees tucked up underneath. This provides a calming effect, reduces systemic venous return, and increases SVR.
    • Oxygen is of limited value since the primary abnormality is reduced pulmonary blood flow.
    • Morphine sulfate, 0.1-0.2 mg/kg IM/SC, may reduce the ventilatory drive and decrease systemic venous return.
    • Phenylephrine, 0.02 mg/kg IV, is used to increase SVR.
    • Treat acidosis with sodium bicarbonate, which may reduce the respiratory center stimulating effect of acidosis.
    • General anesthesia is a last resort.

Consultations

Pediatric cardiology/surgery



The goals of therapy are to reduce the ventilatory drive, decrease systemic venous return, and increase peripheral venous return.

Drug Category: Analgesics

These agents reduce ventilatory drive. Pain control ensures patient comfort and promotes pulmonary toilet. Most analgesics have sedating properties, which are beneficial for patients who are having hypercyanotic episodes.

Drug NameMorphine sulfate (Duramorph, Astramorph, MS Contin)
DescriptionDOC for narcotic analgesia because of its reliable and predictable effects, safety profile, and ease of reversibility with naloxone.
Administered IV, may be dosed in number of ways and commonly titrated until desired effect obtained.
Pediatric Dose0.05-0.2 mg/kg dose IV prn; not to exceed 15 mg/dose
ContraindicationsDocumented hypersensitivity; hypotension; potentially compromised airway with uncertain rapid airway control; respiratory depression; nausea; emesis; constipation; urinary retention
InteractionsPhenothiazines may antagonize analgesic effects; TCAs, MAOIs, and other CNS depressants may potentiate adverse effects
PregnancyB - Usually safe but benefits must outweigh the risks.
PrecautionsAvoid in hypotension, respiratory depression, nausea, emesis, constipation, and urinary retention; caution in atrial flutter and other supraventricular tachycardias; has vagolytic action and may increase ventricular response rate

Drug Category: Alpha-adrenergic agonist

These agents improve hemodynamic status by improving myocardial contractility and increasing heart rate, resulting in increased cardiac output. Peripheral resistance is increased by vasoconstriction. Increased cardiac output and increased peripheral resistance increase blood pressure.

Drug NamePhenylephrine (Neo-Synephrine)
DescriptionStrong postsynaptic alpha-receptor stimulant with little beta-adrenergic activity; produces vasoconstriction of arterioles, increasing peripheral venous return.
Pediatric Dose5-20 mcg/kg/dose IV bolus q10-15min prn
0.1 mg/dose IV/SC q1-2h prn
0.1-0.5 mcg/kg/min IV infusion
ContraindicationsDocumented hypersensitivity; severe hypertension; ventricular tachycardia
InteractionsBretylium may potentiate action on adrenergic receptors, possibly resulting in arrhythmias; MAOIs may significantly enhance adrenergic effects, and pressor response may be increased 2- to 3-fold; guanethidine may increase pressor response of direct-acting vasopressors, possibly resulting in severe hypertension
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsCaution in elderly patients, hyperthyroidism, myocardial disease, bradycardia, partial heart block or severe arteriosclerosis; in hypovolemia, not substitute for replacement of blood, fluids and electrolytes, and plasma (these should be restored promptly when loss has occurred)



Further Inpatient Care

  • Palliative surgery
    • Blalock-Taussig shunt
    • Pott procedure
    • Waterston shunt
  • Total surgical correction with patch closure of the VSD and relief of the ventricular outflow obstruction is preferred (see Image 4).

Further Outpatient Care

  • Good dental hygiene
  • Endocarditis prophylaxis
  • Arrhythmia prophylaxis may be warranted.

Complications

  • Erythrocytosis
  • Brain abscess
  • Acute gouty arthritis
  • Infective endocarditis
  • Cerebrovascular thrombosis
  • Delayed puberty
  • Postoperative complications
    • Congestive heart failure (right or left, residual outflow obstruction, VSD, and/or pulmonic regurgitation
    • Atrial flutter, ventricular arrhythmias, right bundle-branch block, or left anterior hemiblock
    • Infective bacterial endocarditis

Prognosis

  • If right ventricular outflow tract obstruction is severe, the mortality rate is high without palliative or corrective surgery.

Patient Education



Special Concerns

  • Hypoxic tet spells
  • Physical and cognitive growth impairment
  • Brain abscess and stroke, secondary to the right-to-left shunt
  • Infective endocarditis
  • Polycythemia



Media file 1:  Anatomic findings in tetralogy of Fallot.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Image

Media file 2:  Uplifted apex and absence of pulmonary artery segment typifies the "coeur en sabot" (ie, boot-shaped heart) of tetralogy of Fallot.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  X-RAY

Media file 3:  Typical preoperative ECG for tetralogy of Fallot.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  ECG

Media file 4:  Typical findings on postoperative ECG for tetralogy of Fallot.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  ECG



  • Balaji S. Medical therapy for sudden death. Pediatr Clin North Am. Oct 2004;51(5):1379-87. [Medline].
  • Goldmuntz E. The genetic contribution to congenital heart disease. Pediatr Clin North Am. Dec 2004;51(6):1721-37, x. [Medline].
  • Kirklin JW, Barrett-Boyes BGF. Ventricular septal defect and pulmonary stenosis or atresia. Cardiac Surgery. 1993;2:861-1012.
  • Nadas AS. Tetralogy of fallot. In: Nadas Pediatric Cardiology. Hanley & Belfus;1992:471-93.
  • Park MK. Tetralogy of fallot. In: Pediatric Cardiology for Practitioners. 3rd ed. Mosby-Year Book;1996:168-75.
  • Silverman NH. Tetralogy of fallot and related lesions. In: Pediatric Echocardiography. Lippincott Williams & Wilkins;1992:195-214.
  • Snider AR, Serwer GA. Defects in cardiac septation. In: Echocardiography in Pediatric Heart Disease. Mosby-Year Book;1990:150-3.
  • Woods WA, Schutte DA, McCulloch MA. Care of children who have had surgery for congenital heart disease. Am J Emerg Med. Jul 2003;21(4):318-27. [Medline].
  • Zuberhuler JH. Tetralogy of Fallot. In: Heart Disease in Infants, Children and Adolescents. 2nd ed. 1995:998-1026.

Tetralogy of Fallot excerpt

Article Last Updated: Mar 22, 2006